Head-to-head · WeighScore
MANÜ Telehealth vs NowPatient
The verdict
MANÜ Telehealth takes it — 72.2/100 to 65.5/100.
MANÜ Telehealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | MANÜ Telehealth | NowPatient |
|---|---|---|
| WeighScore | 72.2/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #83 | #217 |
| Semaglutide | $120/mo (compounded) | $1,349/mo (brand Wegovy) |
| Tirzepatide | $150/mo (compounded) | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #83 · C
Strengths
- Compounded GLP-1s advertised from about $4-$5/day
- 100% online with free discreet shipping and no insurance needed
- Compounds exclusively from US 503A pharmacies
- Add-on options like MIC Ultraburn and NAD+
Where it loses points
- Per-dose pricing is gated behind login/signup, not public
- State availability changes and is only confirmed at signup
- Compounded medications are not FDA-evaluated
Graded #217 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.